Home Tags Alzheimer’s Disease

Alzheimer’s Disease Related Content

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

vascular dementia

Causes and progression of vascular dementia

Helen Green, Dementia Specialist Nurse on Dementia UK’s Admiral Nurse Dementia Helpline, charts the causes and progression of vascular dementia.
social care system

Why a reformed social care system in the UK cannot wait

Fiona Carragher, Director of Research and Influencing at Alzheimer’s Society walks us through why a reformed social care system in the UK cannot wait.
Dementia research in the UK

Dementia research in the UK and COVID-19

Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
dementia tech

Dementia Tech: Overcoming barriers to innovation post-pandemic

Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.
people with dementia, research

Why do people with dementia often go missing?

New research by the University of East Anglia found that 70% of people with dementia go missing - but why? 
early signs of dementia, mapping

Scientists propose new strategy to identify early signs of dementia

A new 'white matter lesion' mapping tool can find early signs of dementia, with more than 70% accuracy in measuring mental decline.
Neurodegenerative disease research

JPND: The largest global collaborative initiative for neurodegenerative disease research

Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.
alzheimer’s disease

Alzheimer’s disease: Incurable but preventable?

Jonathan Baker of, GBS Clinic, sheds light on the current extent of our knowledge of Alzheimer’s disease.
blood test Alzheimer's

New blood test could improve detection of Alzheimer’s

A new blood test shows promise in detecting Alzheimer’s as early as 20 years before the onset of cognitive impairment, according to researchers.
racial discrimination

Racial discrimination impacts cognitive function in African-American women

Researchers from Boston University, have found that incidents of racial discrimination are associated with lower subjective cognitive function (SCF) among African-American women.
developing dementia

Diabetes significantly increases the risk of developing dementia

Here, Dr Deborah Lee, Dr Fox Online Pharmacy, explores the link between diabetes and the increased risk of developing dementia.
severe covid-19

Dementia gene doubles risk of developing severe COVID-19

Researchers at the University of Exeter Medical School and the University of Connecticut School of Medicine found that a faulty gene linked to dementia doubles the risk of developing severe COVID-19.

April 2020 North America Analysis

In this North America April 2020 edition, David Goff at the National Heart, Lung, and Blood Institute, details the support for heart and vascular health research.
nitric oxide

Chemistry analysis: Microfluidic detection of intracellular nitric oxide levels

Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.
alzheimer’s and dementia funding

Alzheimer’s and dementia funding rises in the U.S.

Rachel Conant, Vice President Federal Affairs, Alzheimer’s Association and Alzheimer’s Impact Movement, provides us with an update on Alzheimer’s and dementia funding rises in the United States.
Alzheimer’s disease progression

Graph theory in the study of Alzheimer’s disease progression

María J. Peláez1, Prashant Dogra1, Zhihui Wang1, Vittorio Cristini1 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA.
difference between dementia and alzheimer’s

Understanding the difference between Dementia and Alzheimer’s

Ella Hendrix, Writer, takes it back to basics and explains the difference between Dementia and Alzheimer's disease
neurodegenerative diseases, protein

A brief overview of advances in neurodegenerative diseases

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.
vitamin b12

Vitamin B12 and brain health of older people

Here, Professor Timothy Kwok discusses the impact of vitamin B12 on the brain health of older people.
data linkage, health longevity

Data linkage and sharing for healthy longevity: A global challenge

Data linkage and sharing for healthy longevity together present a global challenge, in the view of Prof Makoto Suematsu, Japan Agency for Medical Research and Development and Rihana Diabo at the World Economic Forum.

Follow Open Access Government